JORDIN SWANSON: Open Payments
NPI 1861148645 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,734 in 55 payments from 10 companies in 2025. Trend: 2023 $1,556 · 2024 $1,442 · 2025 $1,734
Food & beverage: $1,734
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $313 |
| ABBVIE INC. | 10 | $308 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $264 |
| Janssen Biotech, Inc. | 3 | $191 |
| Ardelyx, Inc. | 9 | $187 |
| Celltrion USA Inc. | 4 | $177 |
| Lilly USA, LLC | 3 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: DUPIXENT, XIFAXAN, TREMFYA, IBSRELA, ZYMFENTRA, ZEPBOUND, VEGZELMA, ENTYVIO.
Industry payments across NJ — which companies pay providers there.
